REG - CVS Group plc - Exercise of Options and Total Voting Rights

CVSAnnouncement

30/06/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220630:nRSd3306Qa&default-theme=true

RNS Number : 3306Q  CVS Group plc  30 June 2022

30 June 2022

CVS Group plc

("CVS" or the "Company")

Exercise of Options and Total Voting Rights

CVS, one of the UK's leading providers of integrated veterinary services,
confirms that certain employees have exercised options during June under the
Company's Save As You Earn (SAYE) 2021 scheme (together, the "SAYE Exercise")
totalling 35,242 ordinary shares of 0.2 pence each ("Ordinary Shares").
Admission of the 35,242 new Ordinary Shares has been satisfied via the block
listing for the SAYE 2021 Scheme.

Following the issue of these new Ordinary Shares, which rank pari passu in all
respects with the Company's existing Ordinary Shares, the Company has a total
issued share capital of 71,120,037 Ordinary Shares, each carrying one voting
right. The Company holds no Ordinary Shares in treasury and the total number
of voting rights is therefore 71,120,037.

This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest, or a change to their interest, in the Company under the FCA's
Disclosure Guidance and Transparency Rules.

 

Contacts:

 CVS Group plc                                                        via MHP Communications
 Richard Fairman, CEO
 Jenny Farrer, Company Secretary
 Singer Capital Markets (Nominated Adviser & Broker)                  +44 20 7496 3000
 Aubrey Powell / Jen Boorer / Rachel Hayes
 MHP Communications (Financial PR)                                    +44 20 3128 8549
 Andrew Jaques / Simon Hockridge / Rachel Farrington / Charles Hirst

 

 

About CVS Group plc (www.cvsukltd.co.uk (http://www.cvsukltd.co.uk/) )

CVS Group is an AIM-quoted fully-integrated provider of veterinary services in
the UK, with practices in the Netherlands and the Republic of Ireland. CVS is
focused on providing high quality clinical services to its customers and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

The Group has c.500 veterinary practices across its three markets, including
eight specialist referral hospitals and 35 dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties), Crematoria
(providing pet cremation and clinical waste disposal for CVS and third-party
practices), Buying Groups and the Group's online retail business ("Animed
Direct").

The Group employs c.7,900 personnel, including c.2,100 veterinary surgeons
and c.2,900 nurses.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVRBDGDLBUDDGDR